Literature DB >> 18923654

A four-year retrospective study of amniocentesis: one centre experience.

A Daniilidis1, H Karydas, V Zournatzi, T Tantanasis, C Giannoulis, J Tzafettas.   

Abstract

AIM: Monitor the performance of the amniocentesis procedure for prenatal diagnosis and particularly the acquisition of results (time to get, success in getting them).
MATERIALS AND METHODS: This is a retrospective review of case notes of all pregnant women undergone amniocentesis in our department during the period 2002-2005. Two main operators performed the procedure, using 22 gauze needle usually and 20 gauze should longer needle was needed. Sevendy three patients undergone amniocentesis. The reasons for having this procedure were: increased risk for Down syndrome in 68% (50/73), maternal request in 24% (18/73), suspicious ultrasound findings in 4% (3/73) and family history in 3% (2/73). Maternal age ranged from 20 to 45 years and the gestation time that amniocentesis was performed was 15 to 23 weeks. Fluorescence in situ hybridization (FISH) and culture were used in order to obtain karyotype results.
RESULTS: In 92% (67/73) of cases one needle pass was needed. FISH and culture were performed in 96% (70/73) of cases, FISH only in 3% (2/73) and culture only in 1% (1/73). The chromosome results were normal in 93% (68/73) of cases, Down's syndrome in 4% (3/73) and Edwards syndrome in 3% (2/73). The outcome of pregnancies was: live births in 89% (65/73), stillbirths at 32 weeks and 35 weeks in 3% (2/73), miscarriages in 1% (1/73 at 19 weeks, 3 weeks after the amniocentesis), terminations in 7% (5/73, due to chromosomal abnormalities). Sixty one women delivered at term (84%) and 6 women (8%) delivered preterm.
CONCLUSION: The post amniocentesis rate of miscarriage is calculated at 1% in our centre. FISH analysis can relieve stress of couples by reducing the waiting time for results.

Entities:  

Keywords:  amniocentesis; chromosomal abnormalities; pregnancy

Year:  2008        PMID: 18923654      PMCID: PMC2464303     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  12 in total

Review 1.  Prenatal diagnosis using interphase fluorescence in situ hybridization (FISH): 2-year multi-center retrospective study and review of the literature.

Authors:  J Tepperberg; M J Pettenati; P N Rao; C M Lese; D Rita; H Wyandt; S Gersen; B White; M M Schoonmaker
Journal:  Prenat Diagn       Date:  2001-04       Impact factor: 3.050

2.  Second-trimester amniocentesis vs. chorionic villus sampling for prenatal diagnosis in multiple gestations.

Authors:  A Antsaklis; A P Souka; G Daskalakis; Y Kavalakis; S Michalas
Journal:  Ultrasound Obstet Gynecol       Date:  2002-11       Impact factor: 7.299

3.  Strategies for the rapid prenatal diagnosis of chromosome aneuploidy.

Authors:  Kathy Mann; Celia Donaghue; Susan P Fox; Zoe Docherty; Caroline Mackie Ogilvie
Journal:  Eur J Hum Genet       Date:  2004-11       Impact factor: 4.246

Review 4.  What's new in prenatal screening and diagnosis?

Authors:  Jennifer A Bubb; Anne L Matthews
Journal:  Prim Care       Date:  2004-09       Impact factor: 2.907

5.  Rapid detection of chromosome aneuploidies in uncultured amniocytes by using fluorescence in situ hybridization (FISH).

Authors:  K Klinger; G Landes; D Shook; R Harvey; L Lopez; P Locke; T Lerner; R Osathanondh; B Leverone; T Houseal
Journal:  Am J Hum Genet       Date:  1992-07       Impact factor: 11.025

6.  Randomised controlled trial of genetic amniocentesis in 4606 low-risk women.

Authors:  A Tabor; J Philip; M Madsen; J Bang; E B Obel; B Nørgaard-Pedersen
Journal:  Lancet       Date:  1986-06-07       Impact factor: 79.321

7.  Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience.

Authors:  Kevin Spencer; Christine E Spencer; Maureen Power; Carolynne Dawson; Kypros H Nicolaides
Journal:  BJOG       Date:  2003-03       Impact factor: 6.531

8.  Rapid prenatal diagnosis of aneuploidies in uncultured amniocytes by fluorescence in situ hybridization. Evaluation of >3,000 cases.

Authors:  B Eiben; W Trawicki; W Hammans; R Goebel; M Pruggmayer; J T Epplen
Journal:  Fetal Diagn Ther       Date:  1999 Jul-Aug       Impact factor: 2.587

9.  UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.

Authors:  R J Snijders; P Noble; N Sebire; A Souka; K H Nicolaides
Journal:  Lancet       Date:  1998-08-01       Impact factor: 79.321

Review 10.  Amniocentesis and chorionic villus sampling for prenatal diagnosis.

Authors:  Z Alfirevic; K Sundberg; S Brigham
Journal:  Cochrane Database Syst Rev       Date:  2003
View more
  1 in total

1.  Does Chorionic Villus Sampling Increase the Risk of Preeclampsia or Gestational Hypertension?

Authors:  Mahboobeh Shirazi; Maryam Rabiei; Fatemeh Rahimi; Shirin Niroomanesh; Fateme Golshahi; Mitra Eftekhar Yazdi
Journal:  Int J Prev Med       Date:  2019-02-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.